
Rejoint received approval under the CE Mark for YourKnee™, a patient-specific system comprising a personalized knee replacement and recovery follow-up.
The YourKnee approach combines elements of 3D printing, patient-specific implants, artificial intelligence and wearables to design personalized implants, surgical simulation and post-op rehabilitation tools for every patient. YourKnee also includes an integrated system of dedicated wearables to remotely monitor and to track recovery and rehabilitation.
Gian Guido Riva, Co-Founder and CEO of Rejoint, said, “We are thrilled to be able to bring the power of personalization in orthopedics to the market. We have long been dedicated to helping improve the lives of patients suffering from knee pain bettering their quality of life. We look forward to witnessing the impact that YourKnee will now be able to have on current generations of patients giving a nod to the healthcare costs reduction.”
Rejoint received approval under the CE Mark for YourKnee™, a patient-specific system comprising a personalized knee replacement and recovery follow-up.
The YourKnee approach combines elements of 3D printing, patient-specific implants, artificial intelligence and wearables to design personalized implants, surgical simulation and...
Rejoint received approval under the CE Mark for YourKnee™, a patient-specific system comprising a personalized knee replacement and recovery follow-up.
The YourKnee approach combines elements of 3D printing, patient-specific implants, artificial intelligence and wearables to design personalized implants, surgical simulation and post-op rehabilitation tools for every patient. YourKnee also includes an integrated system of dedicated wearables to remotely monitor and to track recovery and rehabilitation.
Gian Guido Riva, Co-Founder and CEO of Rejoint, said, “We are thrilled to be able to bring the power of personalization in orthopedics to the market. We have long been dedicated to helping improve the lives of patients suffering from knee pain bettering their quality of life. We look forward to witnessing the impact that YourKnee will now be able to have on current generations of patients giving a nod to the healthcare costs reduction.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





